Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)

Phathom Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapies for gastrointestinal diseases, particularly in the area of acid-related disorders

The company is dedicated to addressing unmet medical needs through its research and development efforts, aiming to provide patients with effective treatment options. By leveraging their expertise in drug development and clinical research, Phathom seeks to bring new molecules to market that enhance patient care and improve health outcomes in the realm of digestive health.